Batch Reports in Pharma: Simplifying Compliance with Review by Exception

Introduction

In the pharmaceutical industry, compliance with regulatory requirements is non-negotiable. One of the cornerstones of maintaining compliance while ensuring product quality is effective batch reporting. However, traditional batch reporting can be time-consuming and labour-intensive, particularly when every detail must be reviewed manually. This is where the concept of Review by Exception (RBE) transforms the process, enabling pharmaceutical manufacturers to focus only on deviations and anomalies rather than analysing every data point.

In this blog, we’ll explore the fundamentals of batch reporting and RBE, their benefits in the pharma industry, and how Réalta Technologies supports this approach using cutting-edge technologies and tools.

What Are Batch Reports in Pharma?

Batch reports are comprehensive documents detailing every stage of a pharmaceutical manufacturing process, from raw material procurement to final product release. These reports serve as critical records for ensuring that each batch of a product complies with stringent regulatory standards, including FDA 21 CFR Part 11 and EU GMP Annex 11.

Batch reports typically include:

While essential for compliance, manually reviewing batch reports is resource-intensive and can delay product release.

What Is Review by Exception (RBE)?

Review by Exception (RBE) is a modern approach to batch reporting that focuses on identifying and analysing deviations or anomalies rather than manually reviewing all data. With this method, only data points or events outside predefined parameters (exceptions) are flagged for review.

RBE eliminates unnecessary reviews of compliant data, streamlining the batch release process while maintaining quality and regulatory adherence.

When a review is performed manually on large quantities of data, the likelihood of missing a deviation is much larger than when with an automated review.

How Réalta Technologies Supports Batch Reporting and RBE

Réalta Technologies is at the forefront of providing pharmaceutical manufacturers with tailored solutions for batch reporting and Review by Exception. By combining industry expertise with advanced technology, we help clients implement efficient, compliant, and scalable systems for managing batch data.

Technologies and Tools We Use:

AVEVA PI System

PI Notifications

PI Batch Interfaces

PI Event Frames (EF Gen)

Syncade MES Integration

RtReports